In addition, a BRCA1-mutation is associated with the more aggressive molecular phenotype of FBC (e.g., triple receptor–negative, oestrogen receptor (ER) negative, progesterone receptor (PR) negative, and HER2 negative), earlier disease onset, and family history of breast cancer [45]. This evidence concerns the gene PGR and complete blood cell count.